PAMELA LEUSCHEN: Open Payments
NPI 1003422478 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 15 payments from 8 companies in 2025. Trend: 2023 $165 · 2024 $395 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $95 |
| Novo Nordisk Inc | 2 | $40 |
| SANOFI-AVENTIS U.S. LLC | 2 | $36 |
| Smith+Nephew, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Viatris Specialty LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: MOUNJARO, Ozempic, TZIELD, COLLAGENASE SANTYL, YUPELRI, Kerendia, GARDASIL 9.
Industry payments across ND — which companies pay providers there.
